成都市药品检验研究院入选

Group 1 - The National Medical Products Administration has announced the list of regulatory science innovation research bases, with Chengdu Institute of Drug Inspection and Research being selected as the only drug inspection institution in Western China to establish a research base in the field of traditional Chinese medicine [1] - The research base will focus on fundamental, key, and cutting-edge technological issues related to drug research and development, production, and quality control, aiming to enhance the scientific, standardized, and international level of drug regulation [1] - Chengdu's traditional Chinese medicine industry has a strong foundation, with an estimated comprehensive output value of approximately 28 billion yuan in 2024, and 126 large-scale enterprises in the sector [1] Group 2 - The area of traditional Chinese medicinal material cultivation exceeds 600,000 acres, with 9 national geographical indication products and an annual export value of 150 million yuan for medicinal materials and extracts [1] - The Hehua Pond traditional Chinese medicinal material market is projected to rank among the top three in the country in terms of scale and efficiency in 2024, and has released the first national traditional Chinese medicinal material commodity index [1] - The development pattern of the industry is characterized by a full-chain approach encompassing cultivation, research, production, and trade [1]